UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
o Rule 13d-1(c)
þ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM BioVentures II, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 2 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM BioVentures II-QP, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 3 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Germany | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 4 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM Asset Management Investors 2001 LLC |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 5 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM BioVentures Strategic Fund, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 6 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM Asset Management II, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 7 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM Asset Management II LLC |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 8 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM BioVentures III GP, L.P. |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 9 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS MPM BioVentures III LLC |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 10 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS Ansbert Gadicke |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 11 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS Luke Evnin |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 12 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS Nicholas Galakatos |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 13 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS Michael Steinmetz |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 14 of 23
CUSIP No. |
00826A 10 9 |
1 | NAMES OF REPORTING PERSONS Kurt Wheeler |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
0 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 15 of 23
Item 1. |
(a) | Name of Issuer |
(b) | Address of Issuers Principal Executive Offices |
Item 2. |
(a) | Name of Person Filing |
(b) | Address of Principal Business Office or, if none, Residence |
(c) | Citizenship |
(d) | Title of Class of Securities |
(e) | CUSIP Number |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c),
check whether the person filing is a: |
Page 16 of 23
Item 4. | Ownership |
(a) | Amount Beneficially Owned: |
MPM BioVentures II, L.P. |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund, L.P. |
0 | |||
MPM Asset Management II, L.P. |
0 | |||
MPM Asset Management II LLC |
0 | |||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke B. Evnin |
0 | |||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 |
MPM BioVentures II, L.P. |
0 | % | ||
MPM BioVentures II-QP, L.P. |
0 | % | ||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | % | ||
MPM Asset Management Investors 2001 LLC |
0 | % | ||
MPM BioVentures Strategic Fund, L.P. |
0 | % | ||
MPM Asset Management II, L.P. |
0 | % | ||
MPM Asset Management II LLC |
0 | % | ||
MPM BioVentures III GP, L.P. |
0 | % | ||
MPM BioVentures III LLC |
0 | % | ||
Ansbert Gadicke |
0 | % | ||
Luke B. Evnin |
0 | % | ||
Nicholas Galakatos |
0 | % | ||
Michael Steinmetz |
0 | % | ||
Kurt Wheeler |
0 | % |
(b) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote |
MPM BioVentures II, L.P. |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund, L.P. |
0 | |||
MPM Asset Management II, L.P. |
0 |
Page 17 of 23
MPM Asset Management II LLC |
0 | |||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke B. Evnin |
0 | |||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 |
(ii) | Shared power to vote or to direct the vote |
MPM BioVentures II, L.P. |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund L.P. |
0 | |||
MPM Asset Management II, L.P. |
0 | |||
MPM Asset Management II LLC |
0 | |||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke B. Evnin |
0 | |||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 |
(iii) | Sole power to dispose or to direct the disposition of |
MPM BioVentures II, LP |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund, L.P. |
0 | |||
MPM Asset Management II, L.P. |
0 | |||
MPM Asset Management II LLC |
0 | |||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
0 | |||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 |
Page 18 of 23
(iv) | Shared power to dispose or to direct the disposition of |
MPM BioVentures II, LP |
0 | |||
MPM BioVentures II-QP, L.P. |
0 | |||
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2001 LLC |
0 | |||
MPM BioVentures Strategic Fund L.P. |
0 | |||
MPM Asset Management II, L.P. |
0 | |||
MPM Asset Management II LLC |
0 | |||
MPM BioVentures III GP, L.P. |
0 | |||
MPM BioVentures III LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke B. Evnin |
0 | |||
Nicholas Galakatos |
0 | |||
Michael Steinmetz |
0 | |||
Kurt Wheeler |
0 |
Item 5. | Ownership of Five Percent or Less of a Class |
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company or Control Person. |
Item 8. | Identification and Classification of Members of the Group |
Item 9. | Notice of Dissolution of a Group |
Item 10. | Certification |
Not Applicable |
Page 19 of 23
MPM BIOVENTURES II, L.P. |
||||
By: | MPM Asset Management II, L.P., | |||
its General Partner |
By: | MPM Asset Management II LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | ||||
Name: | Luke B. Evnin | ||||
Title: | Investment Manager |
MPM BIOVENTURES GMBH & CO.
PARALLEL-BETEILIGUNGS KG |
||||
By: | MPM Asset Management II LP, in its capacity as the Special Limited Partner |
By: | MPM Asset Management II LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM ASSET MANAGEMENT II L.P. |
||||
By: | MPM Asset Management II LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM BIOVENTURES STRATEGIC FUND, L.P. |
||||
By: | MPM BioVentures III GP, L.P., | |||
its General Partner | ||||
By: | MPM BioVentures III LLC, | |||
its General Partner | ||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Series A Member |
MPM BIOVENTURES II-QP, L.P. |
||||
By: | MPM Asset Management II, L.P., | |||
its General Partner |
By: | MPM Asset Management II LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM ASSET MANAGEMENT INVESTORS 2001 LLC |
||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager | |||
MPM ASSET MANAGEMENT II LLC |
||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM BIOVENTURES III GP, L.P. |
||||
By: | MPM BioVentures III LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Series A Member |
Page 20 of 23
MPM BIOVENTURES III LLC |
||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Series A Member | |||
/s/ Luke B. Evnin | ||||
Luke B. Evnin | ||||
/s/ Michael Steinmetz | ||||
Michael Steinmetz | ||||
/s/ Ansbert Gadicke | ||||
Ansbert Gadicke | ||||
/s/ Nicholas Galakatos | ||||
Nicholas Galakatos | ||||
/s/ Kurt Wheeler | ||||
Kurt Wheeler | ||||
Page 21 of 23
MPM BIOVENTURES II, L.P. |
||||
By: | MPM Asset Management II, L.P., | |||
its General Partner |
By: | MPM Asset Management II LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KG |
By: | MPM Asset Management II LP, in its capacity as the Special Limited Partner |
By: | MPM Asset Management II LLC, its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM ASSET MANAGEMENT II L.P. |
||||
By: | MPM Asset Management II LLC, its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM BIOVENTURES STRATEGIC FUND, L.P. |
||||
By: | MPM BioVentures III GP, L.P., | |||
its General Partner |
By: | MPM BioVentures III LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Series A Member |
MPM BIOVENTURES II-QP, L.P. |
||||
By: | MPM Asset Management II, L.P., | |||
its General Partner |
By: | MPM Asset Management II LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM ASSET MANAGEMENT INVESTORS 2001 LLC |
||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM ASSET MANAGEMENT II LLC |
||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Investment Manager |
MPM BIOVENTURES III GP, L.P. |
||||
By: | MPM BioVentures III LLC, | |||
its General Partner |
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Series A Member |
Page 22 of 23
MPM BIOVENTURES III LLC |
||||
By: | /s/ Luke B. Evnin | |||
Name: | Luke B. Evnin | |||
Title: | Series A Member | |||
/s/ Luke B. Evnin | ||||
Luke B. Evnin | ||||
/s/ Michael Steinmetz | ||||
Michael Steinmetz | ||||
/s/ Ansbert Gadicke | ||||
Ansbert Gadicke | ||||
/s/ Nicholas Galakatos | ||||
Nicholas Galakatos | ||||
/s/ Kurt Wheeler | ||||
Kurt Wheeler | ||||
Page 23 of 23